Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank33
3Y CAGR-47.3%
5Y CAGR-41.5%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-47.3%/yr
Quarterly compound
5Y CAGR
-41.5%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.57% |
| Q3 2025 | -0.48% |
| Q2 2025 | -31.85% |
| Q1 2025 | -0.66% |
| Q4 2024 | 0.82% |
| Q3 2024 | 0.42% |
| Q2 2024 | -3.59% |
| Q1 2024 | 1.40% |
| Q4 2023 | 2.30% |
| Q3 2023 | -4.67% |
| Q2 2023 | 1.61% |
| Q1 2023 | -5.15% |
| Q4 2022 | 3.87% |
| Q3 2022 | 3.98% |
| Q2 2022 | 3.40% |
| Q1 2022 | -2.91% |
| Q4 2021 | 3.32% |
| Q3 2021 | 3.52% |
| Q2 2021 | 2.76% |
| Q1 2021 | 0.76% |
| Q4 2020 | 8.28% |
| Q3 2020 | 4.15% |
| Q2 2020 | 1.12% |
| Q1 2020 | -4.53% |
| Q4 2019 | 2.08% |
| Q3 2019 | -2.66% |
| Q2 2019 | 1.43% |
| Q1 2019 | 3.14% |
| Q4 2018 | -22.63% |
| Q3 2018 | 26.00% |
| Q2 2018 | -9.35% |
| Q1 2018 | 46.31% |
| Q4 2017 | 5.11% |
| Q3 2017 | -0.50% |
| Q2 2017 | 2.94% |
| Q1 2017 | 1.47% |
| Q4 2016 | 1.72% |
| Q3 2016 | 3.41% |
| Q2 2016 | 1.74% |
| Q1 2016 | 3.25% |